Heska Corp (HSKA) 10.91 $HSKA
Heska Announces Continued Growth for the First Quarter of 2014
PR Newswire - Thu May 08, 8:00AM CDT
Heska Corporation (NASDAQ: HSKA; "Heska" or the "Company"
, a provider of advanced veterinary diagnostic and other specialty veterinary products, today reported financial results for its first quarter ended March 31, 2014. The Company previously announced the acquisition of 54.6% of Cuattro Veterinary USA, LLC, which was subsequently renamed Heska Imaging US, LLC ("Heska Imaging", and this acquisition is reflected in Heska's consolidated financial results for the first quarter of 2014. The first quarter of 2013 included approximately five weeks' contribution from this acquisition.
Webcast Alert: Heska Announces First Quarter 2014 Earnings Conference Call Webcast
PR Newswire - Thu May 01, 8:00AM CDT
Heska Corporation (Nasdaq: HSKA) announces the following Webcast:
Webcast Alert: Heska Corporation's Annual Meeting of Stockholders Webcast
PR Newswire - Wed Apr 30, 8:00AM CDT
Heska Corporation (Nasdaq: HSKA) announces the following Webcast:
Nasdaq stocks posting largest volume increases
AP - Thu Mar 27, 5:04PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
Nasdaq stocks posting largest percentage increases
AP - Thu Mar 27, 5:03PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
Why Heska (HSKA) Hit a One-Year High Today
at The Street - Thu Mar 27, 1:31PM CDT
Veterinary products company Heska (HSKA) surged to a one-year high of $11.20 as of 2:30 p.m. on Thursday after the company reported its fourth-quarter results. Consolidated revenue increased 27.4% year over year to a record $23.5 million from $18.5...
Heska Announces Record Fourth Quarter Revenue - Up 27% to $23.5 Million
PR Newswire - Thu Mar 27, 8:00AM CDT
Heska Corporation (NASDAQ: HSKA; "Heska" or the "Company", a provider of advanced veterinary diagnostic and other specialty veterinary products, today reported financial results for its fourth quarter and full year ended December 31, 2013. The Company previously announced the acquisition of 54.6% of Cuattro Veterinary USA, LLC ("Cuattro Vet USA", which was subsequently renamed Heska Imaging US, LLC; this acquisition is reflected in Heska's consolidated financial results for the fourth quarter of 2013 with no corresponding contribution in the fourth quarter of 2012 and in Heska's consolidated results for 2013 after February 24, 2013 with no corresponding contribution in 2012.
Webcast Alert: Heska Announces Fourth Quarter and Year End 2013 Earnings Conference Call Webcast
PR Newswire - Tue Mar 25, 4:50PM CDT
Heska Corporation (Nasdaq: HSKA) announces the following Webcast:
This Company's "Dismal" Performance Masks Excellent Opportunity
John Leonard, The Motley Fool - Motley Fool - Fri Feb 14, 1:30PM CST
Abaxis fell sharply after reporting disappointing results last month. However the recent recovery suggests the market is beginning to realize that the cause for the "dismal" results (the CEO's words) is most likely a one-off occurrence rather...
Cambrex (CBM) Jumps: Stock Adds 13.1% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jan 29, 8:46AM CST
Cambrex Corp. was a big mover last session, with shares rising over 13%.
Heska Corporation to Present at the Sidoti Semi-Annual Micro-Cap Conference
PR Newswire - Wed Jan 08, 8:00AM CST
Heska Corporation (NASDAQ:HSKA - News; "Heska" or the "Company", a provider of advanced veterinary diagnostic and other specialty veterinary products, today announced that Robert Grieve, chairman and chief executive officer, will present at the Sidoti & Company, LLC Semi-Annual New York Micro-Cap Conference at 10:40 a.m. ET on January 13, 2014 in the Estate 4/Carnegie Hall room at the Grand Hyatt New York Hotel. Heska management will be available during the day for one-on-one meetings. To schedule a meeting, please contact your Sidoti representative.
Peregrine Pharmaceuticals (PPHM) Soars: Stock Adds 14.5% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Jan 07, 7:57AM CST
Peregrine Pharmaceuticals, Inc. (PPHM) was a big mover last session, as the company saw its shares rise over 14% on the day.
MYGN Faces Payment Cuts, Shares Fall - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jan 06, 2:20PM CST
Shares of Myriad Genetics fell following the announcement by CMS to reduce reimbursement rates on the former's BRACAnalysis test.
Synta Pharmaceuticals Corp. (SNTA) Catches Eye: Stock Surges 11.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jan 06, 7:44AM CST
Synta Pharmaceuticals Corp. was a big mover last session, as the company saw its shares rise nearly 12% on the day.
Synthetic Biologics (SYN) Jumps: Stock Up 5.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jan 03, 7:51AM CST
Synthetic Biologics Inc. was a big mover last session, as its shares rose over 5% on the day.
Immunomedics (IMMU) Jumps: Stock Adds 10.3% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jan 02, 8:25AM CST
Immunomedics was a big mover last session, with shares rising over 10%.
Pluristem (PSTI) Jumps: Stock Adds 8.6% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jan 02, 7:37AM CST
Pluristem Therapeutics, Inc. was a big mover last session, as the company saw its shares nearly 9% on the day.
Edwards Lifesciences Lifted to Hold - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 31, 5:26PM CST
On Dec 28, Zacks Investment Research upgraded medical device major, Edwards Lifesciences Corporation to a Zacks Rank #3 (Hold).
AVEO Pharmaceuticals, Inc. (AVEO) Catches Eye: Stock Rises 8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Dec 31, 7:44AM CST
AVEO Pharmaceuticals, Inc. was a big mover last session, as the company saw its shares rise by 8% on the day.
Heska Announces Continued Growth for the First Quarter of 2014
PR Newswire - Thu May 08, 8:00AM CDT
Heska Corporation (NASDAQ: HSKA; "Heska" or the "Company"
, a provider of advanced veterinary diagnostic and other specialty veterinary products, today reported financial results for its first quarter ended March 31, 2014. The Company previously announced the acquisition of 54.6% of Cuattro Veterinary USA, LLC, which was subsequently renamed Heska Imaging US, LLC ("Heska Imaging", and this acquisition is reflected in Heska's consolidated financial results for the first quarter of 2014. The first quarter of 2013 included approximately five weeks' contribution from this acquisition. Webcast Alert: Heska Announces First Quarter 2014 Earnings Conference Call Webcast
PR Newswire - Thu May 01, 8:00AM CDT
Heska Corporation (Nasdaq: HSKA) announces the following Webcast:
Webcast Alert: Heska Corporation's Annual Meeting of Stockholders Webcast
PR Newswire - Wed Apr 30, 8:00AM CDT
Heska Corporation (Nasdaq: HSKA) announces the following Webcast:
Nasdaq stocks posting largest volume increases
AP - Thu Mar 27, 5:04PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
Nasdaq stocks posting largest percentage increases
AP - Thu Mar 27, 5:03PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
Why Heska (HSKA) Hit a One-Year High Today
at The Street - Thu Mar 27, 1:31PM CDT
Veterinary products company Heska (HSKA) surged to a one-year high of $11.20 as of 2:30 p.m. on Thursday after the company reported its fourth-quarter results. Consolidated revenue increased 27.4% year over year to a record $23.5 million from $18.5...
Heska Announces Record Fourth Quarter Revenue - Up 27% to $23.5 Million
PR Newswire - Thu Mar 27, 8:00AM CDT
Heska Corporation (NASDAQ: HSKA; "Heska" or the "Company"
, a provider of advanced veterinary diagnostic and other specialty veterinary products, today reported financial results for its fourth quarter and full year ended December 31, 2013. The Company previously announced the acquisition of 54.6% of Cuattro Veterinary USA, LLC ("Cuattro Vet USA", which was subsequently renamed Heska Imaging US, LLC; this acquisition is reflected in Heska's consolidated financial results for the fourth quarter of 2013 with no corresponding contribution in the fourth quarter of 2012 and in Heska's consolidated results for 2013 after February 24, 2013 with no corresponding contribution in 2012. Webcast Alert: Heska Announces Fourth Quarter and Year End 2013 Earnings Conference Call Webcast
PR Newswire - Tue Mar 25, 4:50PM CDT
Heska Corporation (Nasdaq: HSKA) announces the following Webcast:
This Company's "Dismal" Performance Masks Excellent Opportunity
John Leonard, The Motley Fool - Motley Fool - Fri Feb 14, 1:30PM CST
Abaxis fell sharply after reporting disappointing results last month. However the recent recovery suggests the market is beginning to realize that the cause for the "dismal" results (the CEO's words) is most likely a one-off occurrence rather...
Cambrex (CBM) Jumps: Stock Adds 13.1% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jan 29, 8:46AM CST
Cambrex Corp. was a big mover last session, with shares rising over 13%.
Heska Corporation to Present at the Sidoti Semi-Annual Micro-Cap Conference
PR Newswire - Wed Jan 08, 8:00AM CST
Heska Corporation (NASDAQ:HSKA - News; "Heska" or the "Company"
, a provider of advanced veterinary diagnostic and other specialty veterinary products, today announced that Robert Grieve, chairman and chief executive officer, will present at the Sidoti & Company, LLC Semi-Annual New York Micro-Cap Conference at 10:40 a.m. ET on January 13, 2014 in the Estate 4/Carnegie Hall room at the Grand Hyatt New York Hotel. Heska management will be available during the day for one-on-one meetings. To schedule a meeting, please contact your Sidoti representative. Peregrine Pharmaceuticals (PPHM) Soars: Stock Adds 14.5% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Jan 07, 7:57AM CST
Peregrine Pharmaceuticals, Inc. (PPHM) was a big mover last session, as the company saw its shares rise over 14% on the day.
MYGN Faces Payment Cuts, Shares Fall - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jan 06, 2:20PM CST
Shares of Myriad Genetics fell following the announcement by CMS to reduce reimbursement rates on the former's BRACAnalysis test.
Synta Pharmaceuticals Corp. (SNTA) Catches Eye: Stock Surges 11.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jan 06, 7:44AM CST
Synta Pharmaceuticals Corp. was a big mover last session, as the company saw its shares rise nearly 12% on the day.
Synthetic Biologics (SYN) Jumps: Stock Up 5.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jan 03, 7:51AM CST
Synthetic Biologics Inc. was a big mover last session, as its shares rose over 5% on the day.
Immunomedics (IMMU) Jumps: Stock Adds 10.3% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jan 02, 8:25AM CST
Immunomedics was a big mover last session, with shares rising over 10%.
Pluristem (PSTI) Jumps: Stock Adds 8.6% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jan 02, 7:37AM CST
Pluristem Therapeutics, Inc. was a big mover last session, as the company saw its shares nearly 9% on the day.
Edwards Lifesciences Lifted to Hold - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 31, 5:26PM CST
On Dec 28, Zacks Investment Research upgraded medical device major, Edwards Lifesciences Corporation to a Zacks Rank #3 (Hold).
AVEO Pharmaceuticals, Inc. (AVEO) Catches Eye: Stock Rises 8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Dec 31, 7:44AM CST
AVEO Pharmaceuticals, Inc. was a big mover last session, as the company saw its shares rise by 8% on the day.
